An evaluation of children with congenital heart disease who participated in the LENA project showed that after 8 weeks of treatment with enalapril, the severity of heart failure score, the left ventricular diastolic dimension z-score, and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels were significantly reduced [2]. The gene discussed is NPPB; the disease is heart failure.